Immatics (IMTX) Accumulated Expenses (2023 - 2025)
Immatics (IMTX) reported Accumulated Expenses of $21.5 million for Q4 2025, up 1175.73% on a YoY basis from $1.7 million in Q4 2024, and up 1175.73% sequentially from $1.7 million in Q4 2024.
Immatics (IMTX) Accumulated Expenses (2023 - 2025) Analysis & Trends
Immatics (IMTX) has 3 years of Accumulated Expenses data on file, last reported at $21.5 million in Q4 2025.
- For the quarter ending Q4 2025, Accumulated Expenses rose 1175.73% year-over-year to $21.5 million; the trailing twelve-month figure through Dec 2025 stood at $21.5 million (up 1175.73% YoY), and the FY2025 full-year result was $20.9 million, up 1122.49% from the prior year.
- Accumulated Expenses grew to $21.5 million in Q4 2025, from $1.7 million in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $21.5 million in Q4 2025 to a low of $1.7 million in Q4 2024.
- A 3-year average of $14.0 million and a median of $18.9 million in 2023 frame the typical range for Accumulated Expenses.
- Across the five-year window, Accumulated Expenses sank 91.06% in 2024 and surged 1175.73% in 2025, its largest moves.
- Tracing IMTX's Accumulated Expenses over 3 years: stood at $18.9 million in 2023, then plunged by 91.06% to $1.7 million in 2024, then surged by 1175.73% to $21.5 million in 2025.
- Business Quant data shows IMTX's Accumulated Expenses at $21.5 million in Q4 2025, $1.7 million in Q4 2024, and $18.9 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Immatics | 1.11 Bn | 1.11 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 21.53 Mn |
| Dec 31, 2024 | 1.69 Mn |
| Dec 31, 2023 | 18.87 Mn |